Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE).

By E. Basch, B. Reeve, S. Mitchell, S. Clauser, L. Minasian, A. Dueck, T. Mendoza, J. Hay, T. Atkinson, A. Abernethy and 16 more. Journal of the National Cancer Institute, 2014

1,047 citations recorded by the source corpus.

Subfields: General Health Professions, Oncology, Public Health, Environmental and Occupational Health

View Paper: https://www.semanticscholar.org/paper/21fd3452e52f35ad16f32e8dbd3b1ed7a4a78e65

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Oncology

1. J. D. de Bono

Citations in the corpus

• Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3. (2016, methodology): “Description of Adverse Events Collection of patient-reported symptoms related to adverse events from treatment should be considered using the National Cancer Institute’s PRO-CTCAE.(36) Inclusion of PRO-CTCAE should be considered in both early- and late-phase clinical trials.”